-
Mashup Score: 1Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States - 3 year(s) ago
Targeting six readily identified poor-quality markers narrowed, but did not eliminate, institutional survival disparities. The greatest impact was in community programs. Residual factors driving persistent institution-level long-term NSCLC survival disparities must be characterized to eliminate them.
Source: CHESTCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2Assessment of Integrated Classifier’s Ability to Distinguish Benign From Malignant Lung Nodules - 3 year(s) ago
Pulmonary nodules pose a diagnostic dilemma for clinicians and patients.1 Guidelines for nodule management emphasize assessment of pretest probability for malignancy (pCA) in determining next steps.2,3 The goal for nodule management is to avoid diagnostic procedures in those with benign disease and expedite diagnosis and treatment in those with malignancy. A rule-out biomarker can assist in…
Source: CHESTCategories: Latest Headlines, PulmonologyTweet-
2-year extended analysis of PANOPTIC trial confirms accuracy of an integrated classifier for indeterminate nodules with probability for malignancy <=50%. Read more in #journalCHEST: https://t.co/ZbRGsSknxQ #CHESTOnc @CHESTOncology https://t.co/pxNMtMizR7
-
-
Mashup Score: 2Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019 - 3 year(s) ago
SP as a form of COVID-19 presentation at the ED is unusual (< 1‰ cases) but is more frequent than in the non-COVID-19 population and could be associated with worse outcomes than SP in non-COVID-19 patients and COVID-19 patients without SP.
Source: CHESTCategories: Latest Headlines, PulmonologyTweet-
Spontaneous pneumothorax in #COVID19 at presentation: - More common vs non-COVID-19 - Could be associated with worse outcomes Read more in #journalCHEST: https://t.co/DwjsT0Qjf2 #CHESTOnc @CHESTOncology https://t.co/VaFRkshlzV
-
-
Mashup Score: 0
This webinar will provide an in-depth review and discussion on lung cancer treatment complications including, but not limited to, immunotherapy-related pneumonitis—a newer challenge facing pulmonologists. Dr. Lynn Tanoue, Professor of Medicine at Yale University, will lead the discussion.
Source: Zoom VideoCategories: Latest Headlines, PulmonologyTweet-
Get an in-depth review and discussion on lung cancer treatment complications, including, but not limited to, immunotherapy-related pneumonitis—a newer challenge facing pulmonologists. Register now: https://t.co/z6IQpr0C9l #CHESTOnc https://t.co/xNEfyFdQXE
-
-
Mashup Score: 0Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial - 3 year(s) ago
Long-term lung cancer-specific survival of stage I lung cancer was greater with low-dose CT imaging than with CXR screening or in the general population, for smaller primary tumor size, and with surgical treatment.
Source: CHESTCategories: Latest Headlines, PulmonologyTweet-
Long-term cancer-specific survival of stage I lung cancer greater with: * LDCT rather than CXR screening * small tumor size * surgical treatment Read more in #journalCHEST: https://t.co/WdvKyqYiOk #CHESTOnc https://t.co/aVPonL9Nlv
-
-
Mashup Score: 6Safety and Efficacy of Bronchoscopy in Critically Ill Patients With Coronavirus Disease 2019 - 3 year(s) ago
Coronavirus disease 2019 (COVID-19) can progress to severe respiratory failure that requires intubation and mechanical ventilation, with a grim prognosis in this subset of patients.1-4 Despite the perceived increased risk from aerosol-generating procedures, data from prior severe acute respiratory syndrome suggests no increased transmission from bronchoscopy.5 There is a paucity of data regarding…
Source: CHESTCategories: Latest Headlines, PulmonologyTweet-
Study reports safety and efficacy of bronchoscopy in patients critically ill with #COVID19: https://t.co/H6ZksxIIxB #journalCHEST #CHESTOnc https://t.co/nKRwKwZecy
-
-
Mashup Score: 0
This webinar will provide learners with a deeper understanding of the role of EBUS-TBNA in the diagnosis and staging of advanced lung cancer with a special emphasis on obtaining adequate tissue for biomarker testing. Dr. Michael Machuzak, attending consultant and interventional pulmonologist, will lead the discussion.
Source: Zoom VideoCategories: Latest Headlines, PulmonologyTweet-
Join us tomorrow at 4 pm CT for Role of the Pulmonologist in Tissue Acquisition, Specimen Handling, and Molecular Testing in Late-Stage NSCLC. Register now: https://t.co/MSod5x6rPw #CHESTOnc https://t.co/7RgIMheUYw
-
-
Mashup Score: 2Robotic Bronchoscopy for Peripheral Pulmonary Lesions - 3 year(s) ago
This is the first, prospective, multicenter study of robotic bronchoscopy in patients with PPLs. Successful lesion localization was achieved in 96.2% of cases, with an adverse event rate comparable with conventional bronchoscopic procedures. Additional large prospective studies are warranted to evaluate procedure characteristics, such as diagnostic yield.
Source: CHESTCategories: Latest Headlines, PulmonologyTweet-
BENEFIT study: Robotic bronchoscopy achieved successful localization of 96.2% peripheral pulmonary lesions, with adverse event rate similar to conventional bronchoscopy. https://t.co/hafIBYbCl2 #journalCHEST #CHESTOnc https://t.co/B7LQ9bDDd3
-
-
Mashup Score: 1
Random error in real-world pack-year assessments leads to a substantial rate of misclassifying who should be offered CT screening if a ≥ 30-pack-year criterion is used. However, using a lung cancer risk threshold mitigates the impact of unreliable pack-year information. Decision-makers concerned about the impact of unreliable pack-year information should consider using risk-based approaches to CT…
Source: CHESTCategories: Latest Headlines, PulmonologyTweet-
Using >=30-pack-year threshold rate leads to high rate of eligibility misclassifications. If decision-makers concerned about unreliable pack-year information, consider using risk-based approaches to CT screening: https://t.co/lvU56YjBmX #journalCHEST #CHESTOnc https://t.co/aE8GYSbav1
-
-
Mashup Score: 0PG: Lung Cancer Update: Advances, Paradigm Shift and Challenges | American College of Chest Physicians - 3 year(s) ago
DetailsCME and MOCTuition CME/CE Claim Instructions Lung Cancer Update: Advances, Paradigm Shifts, and Challenges To complete the Education Activity Evaluation for Lung Cancer Update: Advances, Paradigm Shifts, and Challenges, claim CME/CE credits, and download CME/CE certificates and certificates of attendance (COA), please see the instructions below….
Source: hubs.lyCategories: Latest Headlines, PulmonologyTweet-
Get up to date on the latest advances in #lungcancer care and discuss topics in real time in our 2-week course, Lung Cancer Update: Advances, Paradigm Shifts, and Challenges. Learn more: https://t.co/knRJ296zVr #CHESTOnc https://t.co/QKspanRtzC
-
Targeting 6 readily identified markers of poor quality narrowed institutional survival disparities in #lungcancer resections: https://t.co/SkzZjP1iK7 #journalCHEST #CHESTOnc https://t.co/eKVSFVoM23